Lauren A. Chang

Emergency Medicine

8600 Old Georgetown Road, Floor 1
Floor 1
Bethesda, MD 20814

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Journal: Journal of virology

Published: December 29, 2025

Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.

Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.

Journal: Journal of virology

Published: November 05, 2025

A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized mice.

A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized mice.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.

Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.

Journal: bioRxiv : the preprint server for biology

Published: June 06, 2025

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.

Journal: Human vaccines & immunotherapeutics

Published: March 03, 2025

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination drives Th2-skewed response and is reduced with age.

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination drives Th2-skewed response and is reduced with age.

Journal: Research square

Published: February 20, 2025

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age.

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age.

Journal: NPJ vaccines

Published: February 08, 2025

Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models.

Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models.

Journal: Frontiers in immunology

Published: November 07, 2024

Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.

Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.

Journal: bioRxiv : the preprint server for biology

Published: April 08, 2024

Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.

Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 28, 2024

Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.

Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.

Journal: NPJ vaccines

Published: December 20, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026